Real-world evidence to guide healthcare policies in oncology
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Real-world evidence to guide healthcare policies in oncology. / Donia, Marco; Hansen, Steen Werner; Svane, Inge Marie.
I: OncoTarget, Bind 10, Nr. 44, 2019, s. 4513-4515.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Real-world evidence to guide healthcare policies in oncology
AU - Donia, Marco
AU - Hansen, Steen Werner
AU - Svane, Inge Marie
PY - 2019
Y1 - 2019
N2 - Randomized controlled clinical trials (RCTs) in oncology enroll patients who meet strict protocol-specified criteria. Many of these criteria overlap across multiple RCTs. A vast proportion of patients with metastatic cancer do not meet such criteria. Hence, patient populations encountered in clinical practice are essentially different from RCT-populations, questioning the representativeness of these trials. A real-world evidence approach, using data from clinical practice, is increasingly employed to complement the information on drug safety and efficacy obtained from traditional clinical trials.
AB - Randomized controlled clinical trials (RCTs) in oncology enroll patients who meet strict protocol-specified criteria. Many of these criteria overlap across multiple RCTs. A vast proportion of patients with metastatic cancer do not meet such criteria. Hence, patient populations encountered in clinical practice are essentially different from RCT-populations, questioning the representativeness of these trials. A real-world evidence approach, using data from clinical practice, is increasingly employed to complement the information on drug safety and efficacy obtained from traditional clinical trials.
U2 - 10.18632/oncotarget.27077
DO - 10.18632/oncotarget.27077
M3 - Journal article
C2 - 31360300
VL - 10
SP - 4513
EP - 4515
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 44
ER -
ID: 237517357